Related Experiment Video
Updated: Jan 6, 2026

09:07
Murine Model of Epicutaneously-Induced Immunomodulation
Published on: June 24, 2025
412
Polyarteritis nodosa: decreasing incidence in Poland
Krzysztof Kanecki1, Aneta Nitsch-Osuch1, Pawel Gorynski2
1Department of Social Medicine and Public Health, Medical University of Warsaw, Warsaw, Poland.
Archives of Medical Science : AMS
|October 2, 2019
Summary
The incidence of polyarteritis nodosa (PAN) in Poland was 2.4 per million, similar to European rates. PAN incidence decreased between 2008 and 2013, possibly due to reduced hepatitis B rates.
Area of Science:
- Epidemiology
- Vascular Inflammation
Background:
- Polyarteritis nodosa (PAN) is an orphan disease with limited epidemiological data in Poland.
- Hospital morbidity databases are crucial for epidemiological analysis.
- This study offers a Polish perspective for European comparative analysis.
Purpose of the Study:
- To estimate the incidence of polyarteritis nodosa (PAN) in Poland.
- To analyze trends in PAN incidence between 2008 and 2013.
- To compare Polish PAN incidence with European data.
Main Methods:
- Retrospective, population-based study utilizing Polish hospital discharge records (2008-2013).
- Identified 557 patients with first-time hospitalizations for PAN.
- Incidence calculated using data from the National Institute of Public Health.
Main Results:
- The study included 557 patients (36.3% males, 63.7% females) with a median age of 53.
- Average annual PAN incidence in Poland was 2.4 per million.
- A significant decrease in PAN incidence was observed from 3.3 to 1.9 per million (p < 0.001) between 2008 and 2013.
Conclusions:
- PAN incidence in Poland (2.4 per million) is comparable to other European countries.
- A declining trend in PAN incidence was noted from 2008-2013.
- The decrease may be linked to environmental, infectious (hepatitis B), or other factors, warranting further investigation.
More Related Videos
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
215
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
215
Peripheral Artery Disease I: Introduction
275
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
275

